Displaying One Session

View
Channel 3 Educational session

Metastatic breast cancer: HER2-/HR+

Date
23.05.2020
Time
14:30 - 16:00
Chairs
  • Veronique C. Dieras (Rennes, France)
Metastatic breast cancer: HER2-/HR+ (ID 16) Educational session

Introduction

Lecture Time
14:30 - 14:30
Presenter
  • Veronique C. Dieras (Rennes, France)
Session Name
Metastatic breast cancer: HER2-/HR+ (ID 16)
Room
Channel 3
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Veronique C. Dieras (Rennes, France)
Metastatic breast cancer: HER2-/HR+ (ID 16) Educational session

Update CDK4/6 inhibitors: Survival, QoL and toxicity

Lecture Time
14:30 - 14:50
Presenter
  • Nadia Harbeck (Munich, Germany)
Session Name
Metastatic breast cancer: HER2-/HR+ (ID 16)
Room
Channel 3
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Nadia Harbeck (Munich, Germany)
Metastatic breast cancer: HER2-/HR+ (ID 16) Educational session

What is the right sequence?

Lecture Time
14:50 - 15:10
Presenter
  • Nicholas Turner (London, United Kingdom)
Session Name
Metastatic breast cancer: HER2-/HR+ (ID 16)
Room
Channel 3
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Nicholas Turner (London, United Kingdom)
Metastatic breast cancer: HER2-/HR+ (ID 16) Educational session

Targeting PI3CA/AKT/mTOR pathway

Lecture Time
15:10 - 15:30
Presenter
  • Fabrice AndrĂ© (Villejuif, France)
Session Name
Metastatic breast cancer: HER2-/HR+ (ID 16)
Room
Channel 3
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Fabrice AndrĂ© (Villejuif, France)
Metastatic breast cancer: HER2-/HR+ (ID 16) Educational session

Is there a role for immunotherapy in the metastatic disease?

Lecture Time
15:30 - 15:50
Presenter
  • Hope S. Rugo (San Francisco, CA, United States of America)
Session Name
Metastatic breast cancer: HER2-/HR+ (ID 16)
Room
Channel 3
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Hope S. Rugo (San Francisco, CA, United States of America)